Clopidogrel monotherapy versus aspirin monotherapy in females and males after percutaneous coronary intervention: a sex-stratified analysis of the SMART-CHOICE 3 trial
EuroIntervention · 2026
DOI: 10.4244/eij-d-26-00332 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift EuroIntervention, 2026. Verfasst von Woochan Kwon und 36 weiteren Autor:innen. Beteiligte Einrichtung: Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Clopidogrel, Aspirin, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Clopidogrel has emerged as a promising alternative to aspirin monotherapy for maintenance therapy after percutaneous coronary intervention (PCI); however, the optimal antiplatelet strategy according to sex remains controversial. AIMS: We aimed to investigate whether the treatment effect of antiplatelet therapy differs according to sex. METHODS: This study was a prespecified substudy of the SMART-CHOICE 3 trial. Patients at high risk of recurrent ischaemic events who had completed the standard duration of dual antiplatelet therapy after PCI were randomly assigned to receive clopidogrel or aspirin monotherapy. The primary endpoint was a composite of all-cause death, myocardial infarction, or stroke. RESULTS: A total of 5,506 patients, including 1,002 females and 4,504 males, were enrolled in South Korea. Females had a higher risk profile than males; however, the incidence of the primary endpoint did not differ significantly between females and males (6.7% vs 5.2%, adjusted hazard ratio [HR] 0.89, 95% confidence interval [CI]: 0.62-1.28; p=0.537). Clopidogrel, compared with aspirin, significantly reduced the primary endpoint in females (4.3% vs 9.4%, adjusted HR 0.45, 95% CI: 0.24-0.85; p=0.014) but not in males (4.4% vs 6.0%, adjusted HR 0.77, 95% CI: 0.56-1.07; p=0.116). There was no significant interaction between sex and the antiplatelet therapy (p for interaction=0.288). CONCLUSIONS: In patients with remote PCI and a high risk of recurrent ischaemic events, clopidogrel monotherapy showed a directionally consistent reduction in the composite endpoint of all-cause death, myocardial infarction, or stroke compared with aspirin in both females and males. No significant sex-by-treatment interaction was observed, supporting the consistency of the treatment effect across sexes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
- Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, South Korea.
- Uijeongbu St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
- Wonkwang University Hospital, Iksan, South Korea.
Zitieren
APA
Kwon, W., Choi, K. H., Park, Y. H., Jeong, J. O., Kim, C. J., Yun, K. H., Lee, H. C., Chang, K., Park, M. W., Bae, J. W., Doh, J. H., Cho, B. R., Kim, H. Y., Kim, W., Kim, U., Rha, S. W., Hong, Y. J., Lee, H. J., Ahn, S. G., …, & Smart-Choice Investigators, O. B. O. T. (2026). Clopidogrel monotherapy versus aspirin monotherapy in females and males after percutaneous coronary intervention: a sex-stratified analysis of the SMART-CHOICE 3 trial. EuroIntervention. https://doi.org/10.4244/eij-d-26-00332
Vancouver
Kwon W, Choi KH, Park YH, Jeong JO, Kim CJ, Yun KH, et al. Clopidogrel monotherapy versus aspirin monotherapy in females and males after percutaneous coronary intervention: a sex-stratified analysis of the SMART-CHOICE 3 trial. EuroIntervention. 2026. doi:10.4244/eij-d-26-00332
BibTeX
@article{Kwon2026,
author = {Kwon, Woochan and Choi, Ki Hong and Park, Yong Hwan and Jeong, Jin-Ok and Kim, Chan Joon and Yun, Kyeong Ho and Lee, Han Cheol and Chang, Kiyuk and Park, Mahn-Won and Bae, Jang-Whan and Doh, Joon-Hyung and Cho, Byung Ryul and Kim, Hee-Yeol and Kim, Weon and Kim, Ung and Rha, Seung-Woon and Hong, Young Joon and Lee, Hyun-Jong and Ahn, Sung Gyun and Kim, Doo-Il and Cho, Jang Hyun and Her, Sung Ho and Jeon, Doo Soo and Han, Seung Hwan and Lee, Jin-Bae and Lee, Cheol Whan and Kang, Danbee and Lee, Joo Myung and Park, Taek Kyu and Yang, Jeong Hoon and Lee, Soo-Youn and Choi, Seung-Hyuk and Gwon, Hyeon-Cheol and Song, Young Bin and Lee, Jong-Young and Hahn, Joo-Yong and Smart-Choice Investigators, On Behalf Of The},
title = {Clopidogrel monotherapy versus aspirin monotherapy in females and males after percutaneous coronary intervention: a sex-stratified analysis of the SMART-CHOICE 3 trial},
journal = {EuroIntervention},
year = {2026},
doi = {10.4244/eij-d-26-00332}
}
EUVIMED